STOCK TITAN

[Form 3] Albemarle Corporation Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Krupa Ander C., General Counsel & Secretary of Albemarle Corporation, reported beneficial ownership of 4,341 common shares, consisting of 1,560 issued shares and 2,781 restricted stock units granted across 2023–2025 with staggered vesting through 2028. She also disclosed 2,676 stock options: 1,608 exercisable 02/27/2028 (exp. 02/26/2035) at $78.97 and 1,068 exercisable 02/22/2027 (exp. 02/21/2034) at $118.18. All holdings and vesting terms are reported on Form 3.

Krupa Ander C., Direttore legale & Segretario societario di Albemarle Corporation, ha dichiarato la proprietà effettiva di 4,341 azioni ordinarie, costituite da 1,560 azioni emesse e 2,781 unità azionarie vincolate (restricted stock units) assegnate nel periodo 2023–2025 con maturazione scaglionata fino al 2028. Ha inoltre comunicato 2,676 opzioni su azioni: 1,608 esercitabili 02/27/2028 (scad. 02/26/2035) a $78.97 e 1,068 esercitabili 02/22/2027 (scad. 02/21/2034) a $118.18. Tutte le partecipazioni e i termini di maturazione sono riportati nel Modulo 3.

Krupa Ander C., Asesora jurídica general & Secretaria de Albemarle Corporation, declaró la titularidad efectiva de 4,341 acciones ordinarias, compuestas por 1,560 acciones emitidas y 2,781 unidades de acciones restringidas otorgadas entre 2023–2025 con vesting escalonado hasta 2028. También divulgó 2,676 opciones sobre acciones: 1,608 ejercitables 02/27/2028 (venc. 02/26/2035) a $78.97 y 1,068 ejercitables 02/22/2027 (venc. 02/21/2034) a $118.18. Todas las participaciones y los términos de vesting se informan en el Formulario 3.

Krupa Ander C., Albemarle Corporation의 법률총괄 & 회사비서로서 4,341 보통주에 대한 실소유권을 신고했습니다. 이는 1,560 발행주와 2023–2025년에 부여되어 단계적으로 베스팅되어 2028까지 완성되는 2,781 제한주식단위(RSU)로 구성됩니다. 또한 2,676 주식매수선택권을 공개했으며, 그 중 1,608주는 02/27/2028(만료 02/26/2035)에 행사 가능(행사가 $78.97), 1,068주는 02/22/2027(만료 02/21/2034)에 행사 가능(행사가 $118.18)합니다. 모든 보유내역과 베스팅 조건은 Form 3에 보고되어 있습니다.

Krupa Ander C., conseillère juridique générale & secrétaire d'Albemarle Corporation, a déclaré la détention effective de 4,341 actions ordinaires, comprenant 1,560 actions émises et 2,781 unités d'actions restreintes attribuées entre 2023–2025 avec un vesting échelonné jusqu'en 2028. Elle a également divulgué 2,676 options d'achat d'actions : 1,608 exerçables le 02/27/2028 (exp. 02/26/2035) à $78.97 et 1,068 exerçables le 02/22/2027 (exp. 02/21/2034) à $118.18. Toutes les positions et conditions de vesting sont déclarées dans le formulaire 3.

Krupa Ander C., General Counsel & Corporate Secretary bei Albemarle Corporation, meldete wirtschaftliches Eigentum an 4,341 Stammaktien, bestehend aus 1,560 ausgegebenen Aktien und 2,781 Restricted Stock Units, gewährt in den Jahren 2023–2025 mit gestaffelter Vesting bis 2028. Sie gab außerdem 2,676 Aktienoptionen an: 1.608 ausübbar am 02/27/2028 (abl. 02/26/2035) zum Preis von $78.97 und 1.068 ausübbar am 02/22/2027 (abl. 02/21/2034) zum Preis von $118.18. Alle Bestände und Vesting-Bedingungen sind im Formular 3 angegeben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider Form 3 reports 4,341 shares and 2,676 options; disclosure is informational and not a material corporate event.

The filing provides clear, itemized disclosure of current equity holdings for Krupa Ander C., including the exact split between issued shares and RSUs and full option schedules with exercise prices and expiration dates. This is a standard Section 16 filing that notifies the market of insider holdings rather than indicating a transaction or change in control. The specific numbers and vesting/exercise timelines are useful for monitoring future potential insider exercises or vesting-related sales.

TL;DR: Form 3 documents officer equity exposure and multi-year RSU vesting; relevant for compliance and disclosure records.

The report lists detailed equity compensation components: 2,781 RSUs with discrete vesting dates (2026, 2027, 2028) and 2,676 options with specified exercisable dates, prices, and expirations. For governance and compliance teams, these explicit vesting and option schedules help track insider lockup windows and potential future reportable transactions. The filing is descriptive and aligned with routine reporting obligations.

Krupa Ander C., Direttore legale & Segretario societario di Albemarle Corporation, ha dichiarato la proprietà effettiva di 4,341 azioni ordinarie, costituite da 1,560 azioni emesse e 2,781 unità azionarie vincolate (restricted stock units) assegnate nel periodo 2023–2025 con maturazione scaglionata fino al 2028. Ha inoltre comunicato 2,676 opzioni su azioni: 1,608 esercitabili 02/27/2028 (scad. 02/26/2035) a $78.97 e 1,068 esercitabili 02/22/2027 (scad. 02/21/2034) a $118.18. Tutte le partecipazioni e i termini di maturazione sono riportati nel Modulo 3.

Krupa Ander C., Asesora jurídica general & Secretaria de Albemarle Corporation, declaró la titularidad efectiva de 4,341 acciones ordinarias, compuestas por 1,560 acciones emitidas y 2,781 unidades de acciones restringidas otorgadas entre 2023–2025 con vesting escalonado hasta 2028. También divulgó 2,676 opciones sobre acciones: 1,608 ejercitables 02/27/2028 (venc. 02/26/2035) a $78.97 y 1,068 ejercitables 02/22/2027 (venc. 02/21/2034) a $118.18. Todas las participaciones y los términos de vesting se informan en el Formulario 3.

Krupa Ander C., Albemarle Corporation의 법률총괄 & 회사비서로서 4,341 보통주에 대한 실소유권을 신고했습니다. 이는 1,560 발행주와 2023–2025년에 부여되어 단계적으로 베스팅되어 2028까지 완성되는 2,781 제한주식단위(RSU)로 구성됩니다. 또한 2,676 주식매수선택권을 공개했으며, 그 중 1,608주는 02/27/2028(만료 02/26/2035)에 행사 가능(행사가 $78.97), 1,068주는 02/22/2027(만료 02/21/2034)에 행사 가능(행사가 $118.18)합니다. 모든 보유내역과 베스팅 조건은 Form 3에 보고되어 있습니다.

Krupa Ander C., conseillère juridique générale & secrétaire d'Albemarle Corporation, a déclaré la détention effective de 4,341 actions ordinaires, comprenant 1,560 actions émises et 2,781 unités d'actions restreintes attribuées entre 2023–2025 avec un vesting échelonné jusqu'en 2028. Elle a également divulgué 2,676 options d'achat d'actions : 1,608 exerçables le 02/27/2028 (exp. 02/26/2035) à $78.97 et 1,068 exerçables le 02/22/2027 (exp. 02/21/2034) à $118.18. Toutes les positions et conditions de vesting sont déclarées dans le formulaire 3.

Krupa Ander C., General Counsel & Corporate Secretary bei Albemarle Corporation, meldete wirtschaftliches Eigentum an 4,341 Stammaktien, bestehend aus 1,560 ausgegebenen Aktien und 2,781 Restricted Stock Units, gewährt in den Jahren 2023–2025 mit gestaffelter Vesting bis 2028. Sie gab außerdem 2,676 Aktienoptionen an: 1.608 ausübbar am 02/27/2028 (abl. 02/26/2035) zum Preis von $78.97 und 1.068 ausübbar am 02/22/2027 (abl. 02/21/2034) zum Preis von $118.18. Alle Bestände und Vesting-Bedingungen sind im Formular 3 angegeben.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Krupa Ander C.

(Last) (First) (Middle)
4250 CONGRESS STREET
SUITE 900

(Street)
CHARLOTTE NC 28209

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/29/2025
3. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel & Sec
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 4,341(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options 02/27/2028 02/26/2035 Common Stock 1,608 $78.97 D
Stock Options 02/22/2027 02/21/2034 Common Stock 1,068 $118.18 D
Explanation of Responses:
1. The Reporting Person's holdings reported in Table 1, Column 2 include: 1,560 shares of Common Stock; 384 Restricted Stock Units ("RSUs") granted on February 24, 2023, which vest 100% on February 24, 2026; 441 RSUs granted on February 22, 2024, which vest 100% on February 22, 2027; and 1,956 RSUs granted on February 27, 2025, which vest 100% on February 27, 2028. Vesting of all RSUs reported above is subject to the terms of the applicable award agreement.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Rebekah Richards, Attorney-in-Fact 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Albemarle Corp

NYSE:ALB

ALB Rankings

ALB Latest News

ALB Latest SEC Filings

ALB Stock Data

7.92B
117.18M
0.39%
98.76%
12.52%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
CHARLOTTE